Position in ABBV
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$24,384,670
+$3,543,691 QoQ
Shares Held
96,903
+1.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
1.54%
of 13F equity value
Holder Rank
#545
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sound Income Strategies, LLC holds $77,276,482 across 11 Drug Manufacturers - General names. ABBV ranks #1 (31.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
96,903 | $24,384,670 | |
| 2 | PFE |
Pfizer Inc
|
805,732 | $19,402,026 | |
| 3 | GSK |
GSK plc
|
339,055 | $17,773,263 | |
| 4 | LLY |
ELI LILLY & Co
|
5,822 | $6,983,082 | |
| 5 | SNY |
Sanofi
|
90,957 | $3,880,225 | |
| 6 | JNJ |
Johnson & Johnson
|
9,354 | $2,375,635 | |
| 7 | AMGN |
Amgen Inc
|
2,246 | $813,321 | |
| 8 | MRK |
Merck & Co., Inc.
|
4,917 | $631,834 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,384,670 | 96,903 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $20,840,979 | 95,825 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $21,931,384 | 95,984 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $24,226,724 | 104,633 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $19,744,028 | 106,368 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $20,774,746 | 99,154 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $17,579,861 | 98,930 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $17,688,678 | 89,572 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $18,174,602 | 105,962 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $18,622,274 | 102,264 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $14,431,426 | 93,124 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $18,579,583 | 124,645 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $15,541,374 | 115,352 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $18,728,365 | 117,515 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $16,774,471 | 103,796 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $12,544,877 | 93,472 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $12,998,076 | 84,866 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $13,424,004 | 82,808 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $11,087,635 | 81,888 | Shares | Sole | 2022-01-13 | |
| 2021-09-30 | $8,337,056 | 77,288 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $7,528,744 | 66,839 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $6,522,419 | 60,270 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $4,603,914 | 42,967 | Shares | Sole | 2021-01-11 | |
| 2020-09-30 | $2,958,965 | 33,782 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $2,968,275 | 30,233 | Shares | Sole | 2020-07-13 | |
| 2020-03-31 | $2,103,605 | 27,610 | Shares | Sole | 2020-04-07 | |
| No filing history on record for this holder in this stock. | ||||||